195 related articles for article (PubMed ID: 35608185)
1. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
[TBL] [Abstract][Full Text] [Related]
2. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma.
Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z
BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
4. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
7. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
8. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
9. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
[TBL] [Abstract][Full Text] [Related]
10. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
11. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
Li S; Ran MY; Qiao H
Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
[TBL] [Abstract][Full Text] [Related]
12. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Wang L; Yao B; Yang J; Tian Z; He J
BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
[TBL] [Abstract][Full Text] [Related]
13. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
Ding Y; Li P; Wang W; Liu F
Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
[TBL] [Abstract][Full Text] [Related]
14. EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma.
Cao D; Liu H; Bai L; Tang H
Dig Dis; 2023; 41(2):282-295. PubMed ID: 35636408
[TBL] [Abstract][Full Text] [Related]
15. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
16.
Wen J; Lin B; Lin L; Chen Y; Wang O
Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
[TBL] [Abstract][Full Text] [Related]
17. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract][Full Text] [Related]
18. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Zhang D; Zhou S; Liu B
Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
[TBL] [Abstract][Full Text] [Related]
20. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
